» Related Searches: cancer, breast cancer, lung cancer, lung cancer treatment, prostate cancer

Women with early-stage, hormone-sensitive breast cancer are significantly more likely
to beat the disease if they switch to a new drug, according to research to be
published today … 
WOMEN who switch to Arimidex, a new post-op breast cancer drug approved for use in
Scotland this week, increase their chances of survival by 29 per cent, according to a … 
Biotech drug developer Antigenics said its cancer vaccine Oncophage produced a
immune response to cancer of the nervous system … 
LONDON (Reuters) - Switching patients with early breast cancer from a standard
drug to a newer treatment helps them to live longer and improves their odds of
remaining free of … 
The new indication is for Herceptin, in combination with other cancer drugs, for the
treatment of HER2 positive breast cancer after surgery (lumpectomy or mastectomy) … 
… Drug Administration has agreed to expand the use of Genentech Inc.'s breast
cancer drug Herceptin to include women with early-stage cancer who have
undergone surgery, the company said on Thursday … 
Pharmion Corporation has purchased private oncology company Cabrellis, which holds the US
and EU rights to lung cancer drug amrubicin, for $59 million … 
… cancer. The deal was worth $59M, along with two additional payments of $12....
(more) … 
LONDON (Reuters) - Switching patients with early breast cancer from a standard
drug to a newer treatment helps them to live longer and improves their odds of
remaining free of … 
The breast cancer drug Herceptin received expanded federal approval Thursday to
include treatment of some women after they have undergone surgery … 